CN1062869C - New prednisolone derivates - Google Patents
New prednisolone derivates Download PDFInfo
- Publication number
- CN1062869C CN1062869C CN94191673A CN94191673A CN1062869C CN 1062869 C CN1062869 C CN 1062869C CN 94191673 A CN94191673 A CN 94191673A CN 94191673 A CN94191673 A CN 94191673A CN 1062869 C CN1062869 C CN 1062869C
- Authority
- CN
- China
- Prior art keywords
- compound
- epimer
- formula
- mixture
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1023/93-1 | 1993-04-02 | ||
CH102393 | 1993-04-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1120339A CN1120339A (en) | 1996-04-10 |
CN1062869C true CN1062869C (en) | 2001-03-07 |
Family
ID=4200650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94191673A Expired - Lifetime CN1062869C (en) | 1993-04-02 | 1994-03-31 | New prednisolone derivates |
Country Status (21)
Country | Link |
---|---|
US (1) | US5733901A (en) |
EP (1) | EP0701565B1 (en) |
JP (1) | JP3333210B2 (en) |
KR (1) | KR100330941B1 (en) |
CN (1) | CN1062869C (en) |
AT (1) | ATE172739T1 (en) |
AU (1) | AU683463B2 (en) |
BG (1) | BG62491B1 (en) |
CZ (1) | CZ287877B6 (en) |
DE (1) | DE59407183D1 (en) |
DK (1) | DK0701565T3 (en) |
ES (1) | ES2124884T3 (en) |
FI (1) | FI113543B (en) |
HU (1) | HU220868B1 (en) |
NO (1) | NO305990B1 (en) |
NZ (1) | NZ265054A (en) |
PL (1) | PL179489B1 (en) |
RU (1) | RU2132854C1 (en) |
SK (1) | SK281226B6 (en) |
UA (1) | UA45311C2 (en) |
WO (1) | WO1994022899A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19635498A1 (en) * | 1996-09-03 | 1998-03-26 | Byk Gulden Lomberg Chem Fab | Process for epimer enrichment |
DE10055820C1 (en) * | 2000-11-10 | 2002-07-25 | Byk Gulden Lomberg Chem Fab | Preparation of 16,17-cyclohexylmethylene-dioxy-pregnadiene derivative, useful as glucocorticoid, by reacting 16,17-ketal with cyclohexylaldehyde to give high epimeric purity |
IL155274A0 (en) * | 2000-11-10 | 2003-11-23 | Altana Pharma Ag | Process for the production of 16,17[(cylohexylmethylen)bis(oxy)]-dihydroxy-pregna-1,4-dien-3,20-dione |
NZ538954A (en) | 2002-08-30 | 2007-04-27 | Altana Pharma Ag | The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis and allergic conjunctivitis |
EP1572217B1 (en) * | 2002-12-12 | 2008-08-20 | Nycomed GmbH | Combination medicament of r,r-formoterol and ciclesonide |
MY143936A (en) * | 2003-03-27 | 2011-07-29 | Nycomed Gmbh | Process for preparing crystalline ciclesonide with defined particle size |
AU2004246819A1 (en) * | 2003-06-13 | 2004-12-23 | Nycomed Gmbh | Formoterol and ciclesonide combination |
CA2538202C (en) * | 2003-09-15 | 2013-01-15 | Altana Pharma Ag | Use of ciclesonide for the treatment of inflammatory bowel diseases |
PT1670482E (en) | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
PE20050941A1 (en) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | AQUEOUS CYCLESOUND SUSPENSIONS FOR MISTING |
WO2005102354A1 (en) * | 2004-04-20 | 2005-11-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
WO2006027377A1 (en) * | 2004-09-10 | 2006-03-16 | Altana Pharma Ag | Ciclesonide and syk inhibitor combination and methods of use thereof |
CN100345864C (en) * | 2004-10-29 | 2007-10-31 | 天津药业研究院有限公司 | Preparation method of steroid medicine for treating respiration channel disease and its intermediate |
BRPI0611567A2 (en) * | 2005-06-14 | 2016-11-16 | Gilead Sciences Inc | pharmaceutically acceptable compound and / or salts thereof, process for compound synthesis, and aerosol formulation, and use of at least one phenylphosphate mutual prodrug |
WO2007054974A2 (en) * | 2005-09-28 | 2007-05-18 | Arch Pharmalab Limited | A green chemistry process for the preparation of pregnadiene esters |
WO2008015696A2 (en) * | 2006-05-23 | 2008-02-07 | Cadila Healthcare Limited | Process for preparing ciclesonide |
EP2392584A1 (en) * | 2006-09-19 | 2011-12-07 | Cipla Limited | Crystalline Ciclesonide Methanol Solvate Form C |
WO2009112557A2 (en) * | 2008-03-13 | 2009-09-17 | Farmabios S.P.A. | Process for the preparation of pregnane derivatives |
ITMI20080645A1 (en) * | 2008-04-11 | 2009-10-12 | Ind Chimica Srl | PROCEDURE FOR THE PREPARATION OF BUDESONIDE |
AU2010221972B2 (en) * | 2009-03-09 | 2012-07-05 | Mikasa Seiyaku Co., Ltd. | Steroid compound |
WO2011135585A2 (en) | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Aqueous pharmaceutical solution of ciclesonide |
US9109005B2 (en) | 2012-02-23 | 2015-08-18 | Boehringer Ingelheim International Gmbh | Method for manufacturing of ciclesonide |
CN103421075B (en) * | 2012-05-16 | 2017-07-28 | 上海特化医药科技有限公司 | The preparation method of the acetal of pregnane derivatives 16,17 (ketone) |
KR20220119529A (en) | 2016-06-02 | 2022-08-29 | 애브비 인코포레이티드 | Glucocorticoid receptor agonist and immunoconjugates thereof |
AU2018374634A1 (en) | 2017-12-01 | 2020-05-28 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990401A (en) * | 1958-06-18 | 1961-06-27 | American Cyanamid Co | 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids |
GB2247680A (en) * | 1990-09-07 | 1992-03-11 | Elmu Sa | Acetals and esters of 16alpha-hydroxyprednisolone and fluocinolone |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1382614A (en) * | 1972-01-10 | 1975-02-05 | Squibb & Sons Inc | Steroid compositions |
IT1196142B (en) * | 1984-06-11 | 1988-11-10 | Sicor Spa | PROCEDURE FOR THE PREPARATION OF 16.17-ACETALS OF PREGNANIC DERIVATIVES AND NEW COMPOUNDS OBTAINED |
-
1994
- 1994-03-31 CZ CZ19952529A patent/CZ287877B6/en not_active IP Right Cessation
- 1994-03-31 EP EP94913100A patent/EP0701565B1/en not_active Expired - Lifetime
- 1994-03-31 ES ES94913100T patent/ES2124884T3/en not_active Expired - Lifetime
- 1994-03-31 KR KR1019950704088A patent/KR100330941B1/en not_active IP Right Cessation
- 1994-03-31 RU RU95119827A patent/RU2132854C1/en active
- 1994-03-31 SK SK1223-95A patent/SK281226B6/en not_active IP Right Cessation
- 1994-03-31 DK DK94913100T patent/DK0701565T3/en not_active Application Discontinuation
- 1994-03-31 AU AU65381/94A patent/AU683463B2/en not_active Expired
- 1994-03-31 CN CN94191673A patent/CN1062869C/en not_active Expired - Lifetime
- 1994-03-31 DE DE59407183T patent/DE59407183D1/en not_active Expired - Lifetime
- 1994-03-31 PL PL94311474A patent/PL179489B1/en unknown
- 1994-03-31 WO PCT/EP1994/001015 patent/WO1994022899A1/en active IP Right Grant
- 1994-03-31 US US08/530,173 patent/US5733901A/en not_active Expired - Lifetime
- 1994-03-31 JP JP52167794A patent/JP3333210B2/en not_active Expired - Lifetime
- 1994-03-31 NZ NZ265054A patent/NZ265054A/en not_active IP Right Cessation
- 1994-03-31 HU HU9502819A patent/HU220868B1/en unknown
- 1994-03-31 UA UA95094314A patent/UA45311C2/en unknown
- 1994-03-31 AT AT94913100T patent/ATE172739T1/en active
-
1995
- 1995-09-27 BG BG100032A patent/BG62491B1/en unknown
- 1995-09-27 FI FI954579A patent/FI113543B/en not_active IP Right Cessation
- 1995-09-29 NO NO19953861A patent/NO305990B1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990401A (en) * | 1958-06-18 | 1961-06-27 | American Cyanamid Co | 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids |
GB2247680A (en) * | 1990-09-07 | 1992-03-11 | Elmu Sa | Acetals and esters of 16alpha-hydroxyprednisolone and fluocinolone |
Also Published As
Publication number | Publication date |
---|---|
UA45311C2 (en) | 2002-04-15 |
NO953861L (en) | 1995-09-29 |
EP0701565B1 (en) | 1998-10-28 |
FI113543B (en) | 2004-05-14 |
HU9502819D0 (en) | 1995-11-28 |
PL311474A1 (en) | 1996-02-19 |
DE59407183D1 (en) | 1998-12-03 |
CZ287877B6 (en) | 2001-03-14 |
US5733901A (en) | 1998-03-31 |
BG100032A (en) | 1996-05-31 |
EP0701565A1 (en) | 1996-03-20 |
AU6538194A (en) | 1994-10-24 |
FI954579A (en) | 1995-09-27 |
SK122395A3 (en) | 1996-01-10 |
HUT72594A (en) | 1996-05-28 |
HU220868B1 (en) | 2002-06-29 |
NO953861D0 (en) | 1995-09-29 |
CZ252995A3 (en) | 1996-01-17 |
KR100330941B1 (en) | 2002-10-12 |
JPH08508278A (en) | 1996-09-03 |
DK0701565T3 (en) | 1999-07-12 |
JP3333210B2 (en) | 2002-10-15 |
FI954579A0 (en) | 1995-09-27 |
PL179489B1 (en) | 2000-09-29 |
NZ265054A (en) | 1997-08-22 |
AU683463B2 (en) | 1997-11-13 |
WO1994022899A1 (en) | 1994-10-13 |
CN1120339A (en) | 1996-04-10 |
ES2124884T3 (en) | 1999-02-16 |
RU2132854C1 (en) | 1999-07-10 |
ATE172739T1 (en) | 1998-11-15 |
BG62491B1 (en) | 1999-12-30 |
SK281226B6 (en) | 2001-01-18 |
NO305990B1 (en) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1062869C (en) | New prednisolone derivates | |
CA1246544A (en) | Tigogenin-cellobioside for treating hypercholesterolemia and arteriosclerosis | |
WO2001045678A2 (en) | Medicament, a method for its production and the use thereof | |
CN1050195A (en) | As C 17-2017 β-(ring propoxy-) androstane-5-alkene-3 β-pure and mild relative compound that the 4-of cracking acid inhibitor replaces | |
CN1050196A (en) | As C 17-2017 β-(cyclopropyl amino) androstane-5-alkene-3 β-pure and mild relevant compound that the 4-of lyase inhibitors replaces | |
US6310226B1 (en) | Vitamin D analogues | |
WO1995010527A1 (en) | 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use | |
EP0619305B1 (en) | Lactone compound and process of producing thereof | |
JP2003528110A (en) | Method for producing Diels-Alder adduct of sterol 5,7-diene using unsaturated fatty acid catalyst | |
EP0072268B1 (en) | At position 17 esterified and at position 21 thio-esterified steroids, process for their preparation and their utilisation as pharmaceutical preparations | |
JPH05502227A (en) | Use of gibberellins in the treatment of prostatitis and psoriasis | |
FR2518091A1 (en) | 23-DEHYDRO-25-HYDROXYVITAMINE D3, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | |
DE3017015C2 (en) | ||
CH634293A5 (en) | Process for preparing the novel antibiotic derivative dihydroisocyclosporin D | |
EP0003341B1 (en) | 11,17-substituted pregnanes, their preparation and application for the preparation of pharmaceutical compositions | |
DE3621024A1 (en) | 11 beta -Phenyloestrenes and -oestradienes, their preparation and pharmaceutical products containing these | |
FR2444M (en) | ||
EP0005758B1 (en) | Process for the synthesis of the hydroxyacetyl side chain of pregnane steroids, 21-hydroxy 20-oxo-17 alpha pregnanes and pharmaceutical preparations containing them | |
EP0571012A2 (en) | Monoqaternary 2, 16-bispiperidinylandrostane derivatives | |
KR20030022760A (en) | Novel fusidic acid derivatives | |
DE68912422T2 (en) | 19-fluorine or cyano-21-hydroxy-progesterone derivatives as 19-hydroxylase inhibitors. | |
CA2159627C (en) | Novel prednisolone derivatives | |
DE3514272A1 (en) | DERMATICA | |
DE954153C (en) | Process for the preparation of 4-androstene-14 ª ‡ -o1-3, 17-dione | |
EP1594887A2 (en) | Novel steroids and steroid mimetics, method for the production and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: OTANA MEDICINE AG Free format text: FORMER NAME OR ADDRESS: BYK GULDEN LOMBERG CHEM CO. |
|
CP01 | Change in the name or title of a patent holder |
Patentee after: Austana Pharmaceutical GmbH Patentee before: Beek. Gulton. Rahum Berger chemical company |
|
C56 | Change in the name or address of the patentee |
Owner name: NICOMEDES LIMITED LIABILITY COMPANY Free format text: FORMER NAME OR ADDRESS: OTANA MEDICINE AG |
|
CP03 | Change of name, title or address |
Address after: The Federal Republic of Germany Konstanz Patentee after: Nycomed GmbH Address before: The Federal Republic of Germany Konstanz Patentee before: Austana Pharmaceutical GmbH |
|
C56 | Change in the name or address of the patentee |
Owner name: NYCOMED INC. Free format text: FORMER NAME: NYCOMED GMBH |
|
CP03 | Change of name, title or address |
Address after: Konstanz Patentee after: Nycomed GmbH Address before: The Federal Republic of Germany Konstanz Patentee before: Nycomed GmbH |
|
C56 | Change in the name or address of the patentee |
Owner name: TAKEDA GMBH Free format text: FORMER NAME: NYCOMED INC. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Konstanz Patentee after: Nycomed GmbH Address before: Konstanz Patentee before: Nycomed GmbH |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20140331 Granted publication date: 20010307 |